Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Girard

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|September 11, 2021
Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR cleaved by furinDelia Susan-Resiga, Emmanuelle Girard, Rachid Essalmani, et al.
Nucleic Acids Research|January 28, 2024
H2A.Z is involved in premature aging and DSB repair initiation in muscle fibersEdwige Belotti, Nicolas Lacoste, Arslan Iftikhar, et al.
Fitoterapia|October 21, 2018
N-myristoyltransferases inhibitory activity of ellagitannins from Terminalia bentzoë (L.) L. f. subsp. bentzoëCécile Apel, Jérôme Bignon, María Concepción Garcia-Alvarez, et al.
The Journal of Biological Chemistry|December 22, 2016
The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIADelia Susan-Resiga, Emmanuelle Girard, Robert Scott Kiss, et al.
Cell Reports|February 24, 2017
LSD1 Controls Timely MyoD Expression via MyoD Core Enhancer TranscriptionIsabella Scionti, Shinichiro Hayashi, Sandrine Mouradian, et al.
Human Molecular Genetics|July 24, 2008
Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotoniaMorgane Stum, Emmanuelle Girard, Marie Bangratz, et al.
International Journal of Antimicrobial Agents|August 1, 2018
Antiplasmodial, anti-chikungunya virus and antioxidant activities of 64 endemic plants from the Mascarene IslandsAllison Ledoux, Martine Cao, Olivia Jansen, et al.
Molecular Metabolism|December 25, 2022
Molecular interactions of PCSK9 with an inhibitory nanobody, CAP1 and HLA-C: Functional regulation of LDLR levelsCarole Fruchart Gaillard, Ali Ben Djoudi Ouadda, Lidia Ciccone, et al.
Elife|August 27, 2021
MACF1 controls skeletal muscle function through the microtubule-dependent localization of extra-synaptic myonuclei and mitochondria biogenesisAlireza Ghasemizadeh, Emilie Christin, Alexandre Guiraud, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 26, 2019
Ser-Phosphorylation of PCSK9 (Proprotein Convertase Subtilisin-Kexin 9) by Fam20C (Family With Sequence Similarity 20, Member C) Kinase Enhances Its Ability to Degrade the LDLR (Low-Density Lipoprotein Receptor)Ali Ben Djoudi Ouadda, Marie-Soleil Gauthier, Delia Susan-Resiga, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|September 11, 2021
Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR cleaved by furinDelia Susan-Resiga, Emmanuelle Girard, Rachid Essalmani, et al.
Nucleic Acids Research|January 28, 2024
H2A.Z is involved in premature aging and DSB repair initiation in muscle fibersEdwige Belotti, Nicolas Lacoste, Arslan Iftikhar, et al.
Fitoterapia|October 21, 2018
N-myristoyltransferases inhibitory activity of ellagitannins from Terminalia bentzoë (L.) L. f. subsp. bentzoëCécile Apel, Jérôme Bignon, María Concepción Garcia-Alvarez, et al.
The Journal of Biological Chemistry|December 22, 2016
The Proprotein Convertase Subtilisin/Kexin Type 9-resistant R410S Low Density Lipoprotein Receptor Mutation: A NOVEL MECHANISM CAUSING FAMILIAL HYPERCHOLESTEROLEMIADelia Susan-Resiga, Emmanuelle Girard, Robert Scott Kiss, et al.
Cell Reports|February 24, 2017
LSD1 Controls Timely MyoD Expression via MyoD Core Enhancer TranscriptionIsabella Scionti, Shinichiro Hayashi, Sandrine Mouradian, et al.
Human Molecular Genetics|July 24, 2008
Evidence of a dosage effect and a physiological endplate acetylcholinesterase deficiency in the first mouse models mimicking Schwartz-Jampel syndrome neuromyotoniaMorgane Stum, Emmanuelle Girard, Marie Bangratz, et al.
International Journal of Antimicrobial Agents|August 1, 2018
Antiplasmodial, anti-chikungunya virus and antioxidant activities of 64 endemic plants from the Mascarene IslandsAllison Ledoux, Martine Cao, Olivia Jansen, et al.
Molecular Metabolism|December 25, 2022
Molecular interactions of PCSK9 with an inhibitory nanobody, CAP1 and HLA-C: Functional regulation of LDLR levelsCarole Fruchart Gaillard, Ali Ben Djoudi Ouadda, Lidia Ciccone, et al.
Elife|August 27, 2021
MACF1 controls skeletal muscle function through the microtubule-dependent localization of extra-synaptic myonuclei and mitochondria biogenesisAlireza Ghasemizadeh, Emilie Christin, Alexandre Guiraud, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 26, 2019
Ser-Phosphorylation of PCSK9 (Proprotein Convertase Subtilisin-Kexin 9) by Fam20C (Family With Sequence Similarity 20, Member C) Kinase Enhances Its Ability to Degrade the LDLR (Low-Density Lipoprotein Receptor)Ali Ben Djoudi Ouadda, Marie-Soleil Gauthier, Delia Susan-Resiga, et al.
Pageof 5